Author

Stephen Akanbi

Texas A&M University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:spatial transcriptomics· 2 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

Danielle Fails· 2 shared Mrinmoy SarkariD· 2 shared Olajumoke OgunlusiiD· 2 shared Tapasree Roy SarkariD· 2 shared Akash Agarwal· 1 shared Akshara Singareeka· 1 shared Bani Mallick· 1 shared Bo Lin· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Danielle Fails

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer

Kayla Carter, Olajumoke Ogunlusi, Mrinmoy Sarkar, Stephen Akanbi, Christian Nguyen, Manasa Nekkanti, Akash Agarwal, Danielle Fails, Gayan I. Nawaratna, Cory L. Klemashevich, James J. Cai, Devon J. Boland, Tapasree Roy Sarkar

This study identifies a stromal metabolic program in HER2-low breast cancer that suppresses NK-cell immunity, promoting tumor progression through BCAT1-dependent BCKA production.

bioRxiv · Sep 14, 2026 · PreprintCancer Biology

Spatial immune ecosystems govern therapeutic response in HER2-low breast cancer

Olajumoke Ogunlusi, Soupayan Banerjee, Akshara Singareeka, Stephen Akanbi, Mrinmoy Sarkar, Pritam Dey, Bo Lin, Yingxiang Xu, Tommy Tran, Danielle Fails, Bani Mallick, Gabriela Raso, Debu Tripathy, Tapasree Roy Sarkar

This study uses single-cell spatial transcriptomics to show that dendritic cell states and immune architecture in HER2-low breast cancer influence therapeutic response, with specific immune niches linked to resistance or sensitivity.

bioRxiv · Aug 24, 2026 · PreprintCancer Biology